IP Library Granted Patent US 9,689,031
Granted Patent B2
US 9,689,031 · App. 11/778,018 · Granted Jun 27, 2017

Nicking and extension amplification reaction for the exponential amplification of nucleic acids

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,689,031
App. No.
11/778,018
Granted
Jun 27, 2017
Kind
B2
Abstract

The invention is in general directed to the rapid exponential amplification of short DNA or RNA sequences at a constant temperature.

Claims (24)

1. A method for amplifying a double-stranded nucleic acid target sequence, comprising:

a) contacting a target DNA molecule comprising a double-stranded target sequence having a sense strand and an antisense strand, without, prior to the contacting, subjecting the target DNA molecule to a thermal denaturation step associated with amplification of the target sequence, with:

(1) a forward template and a reverse template, wherein

i) said forward template comprises a nucleic acid sequence comprising a recognition region at the 3′ end that is complementary to the 3′ end of the target sequence antisense strand; a nicking enzyme binding site and a nicking site upstream of said recognition region; and a stabilizing region upstream of said nicking site, wherein the portion of the nucleic acid sequence that is complementary to the 3′ end of the target antisense strand is 8-15 nucleotides in length; wherein when the recognition region of the forward template is hybridized to the target sequence, the stabilizing region of the forward template is not hybridized to the target nucleic acid molecule;

ii) said reverse template comprises a nucleotide sequence comprising a recognition region at the 3′ end that is complementary to the 3′ end of the target sequence sense strand; a nicking enzyme binding site and a nicking site upstream of said recognition region, and a stabilizing region upstream of said nicking site, wherein the portion of the nucleic acid sequence that is complementary to the 3′ end of the target sense strand is 8-15 nucleotides in length; wherein when the recognition region of the reverse template is hybridized to the target sequence, the stabilizing region of the reverse template is not hybridized to the target nucleic acid molecule;

(2) a first nicking enzyme that is capable of nicking at the nicking site of said forward template, and does not nick within said target sequence;

(3) a second nicking enzyme that is capable of nicking at the nicking site of said reverse template and does not nick within said target sequence;

(4) a DNA polymerase; and

b) amplifying the double-stranded nucleic acid target sequence under essentially isothermal conditions; wherein amplification is performed by multiple cycles of said polymerase extending said forward and reverse templates along said target sequence producing a double-stranded nicking site, and said nicking enzymes nicking at said nicking sites, and, following a first round of amplification, at amplified copies of said sites, producing an amplification product.

2. The method of claim 1 , wherein said DNA polymerase is a thermophilic polymerase.

3. The method of claim 1 , wherein said polymerase is selected from the group consisting of Bst (large fragment), and exo-DNA Polymerase.

4. The method of claim 1 , wherein said polymerase is Bst (large fragment).

5. The method of claim 1 , wherein said nicking enzymes nick downstream of the nicking enzyme binding site.

6. The method of claim 1 , wherein said forward and reverse templates comprise nicking enzyme binding sites recognized by the same nicking enzyme and said first and said second nicking enzymes are the same.

7. The method of claim 1 , wherein said nicking enzymes are selected from the group consisting of Nt.BspQI, Nb.BbvCi, Nb.BsmI, Nb.BsrDI, Nb.BtsI, Nt.AlwI, Nt.BbvCI, Nt.BstNBI, Nt.CviPII, Nb.Bpu10I, and Nt.Bpu10I.

8. The method of claim 1 , wherein said target sequence comprises 1 nucleotide more than the sum of the nucleotides of said forward template recognition region and said reverse template recognition region.

9. The method of claim 1 , wherein said target sequence comprises 2 nucleotides more than the sum of the nucleotides of said forward template recognition region and said reverse template recognition region.

10. The method of claim 1 , wherein the target DNA molecule is selected from the group consisting of genomic DNA, plasmid, mitochondrial, and viral DNA.

11. The method of claim 1 , wherein the forward template is provided at the same concentration as the reverse template.

12. The method of claim 1 , wherein the amplification is conducted between 54° C. and 60° C.

13. The method of claim 1 , wherein the amplification reaction is held at a constant temperature for 1 to 10 minutes.

14. The method of claim 1 , further comprising detecting the amplification product.

15. The method of claim 1 , wherein said amplification product is detected by a method selected from the group consisting of gel electrophoresis, mass spectrometry, intercalating dye detection, FRET, molecular beacon detection, surface capture, capillary electrophoresis, incorporation of labeled nucleotides to allow detection by capture, fluorescence polarization, and lateral flow capture.

16. The method of claim 1 , wherein the method comprises amplifying at least two target sequences.

Assignments (10)
CORRECTIVE ASSIGNMENT TO CORRECT THE ATTACHED DOCUMENT PREVIOUSLY RECORDED AT REEL: 052673 FRAME: 0682. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT . Recorded Jan 6, 2022
From: ALERE HEALTH IMPROVEMENT COMPANY
To: NEWCO RD, LLC
Reel/Frame 058565/0833 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 15, 2020
From: ALERE HEALTH IMPROVEMENT COMPANY
To: NEWCO RD, LLC
Reel/Frame 052673/0682 →
CHANGE OF NAME Recorded May 15, 2020
From: NEWCO RD, LLC
To: IONIAN TECHNOLOGIES, LLC
Reel/Frame 052679/0239 →
MERGER Recorded Mar 13, 2020
From: IONIAN TECHNOLOGIES INC.
To: ALERE HEALTH IMPROVEMENT COMPANY
Reel/Frame 052111/0050 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY RECORDED AT REEL 036994, FRAME 0192 AND REEL 037115, FRAME 0498 Recorded Oct 5, 2017
From: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS COLLATERAL AGENT
To: ALERE CONNECT, LLC; ALERE SAN DIEGO, INC. (FKA BIOSITE INC. OR FKA CHOLESTECH CORP. OR FKA HEMOSENSE INC. OR FKA INVERNESS MEDICAL-BIOSTAR INC. OR FKA ISCHEMIA TECHNOLOGIES, INC. OR FKA TWISTDX, INC.); ALERE SCARBOROUGH, INC. (FKA MATRITECH, INC. FKA ADVANTAGE DIAGNOSTICS CORP. OR FKA BINAX, INC. OR FKA MILANO ACQUISITION CORP.); INNOVACON, INC. (FKA APPLIED BIOTECH, INC. OR FKA AMEDITECH INC.); IONIAN TECHNOLOGIES, LLC (FKA IONIAN TECHNOLOGIES, INC.); QUALITY ASSURED SERVICES INC. (FKA ZYCARE INC.); STANDING STONE, LLC; ESCREEN, INC.
Reel/Frame 044213/0258 →
ASSIGNMENT OF IP SECURITY AGREEMENT, PREVIOUSLY RECORDED AT REEL 036994, FRAME 0192 Recorded Nov 16, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS RETIRING ADMINISTRATIVE AGENT
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR ADMINISTRATIVE AGENT
Reel/Frame 037115/0498 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 29, 2015
From: ALERE CONNECT, LLC; ALERE SAN DIEGO, INC. (FKA BIOSITE INC. OR FKA CHOLESTECH CORP. OR FKA HEMOSENSE INC. OR FKA INVERNESS MEDICAL-BIOSTAR INC. OR FKA ISCHEMIA TECHNOLOGIES, INC. OR FKA TWISTDX, INC.); ALERE SCARBOROUGH, INC. (FKA MATRITECH, INC. FKA ADVANTAGE DIAGNOSTICS CORP. OR FKA BINAX, INC. OR FKA MILANO ACQUISITION CORP.); INNOVACON, INC. (FKA APPLIED BIOTECH, INC. OR FKA AMEDITECH INC.); IONIAN TECHNOLOGIES, LLC (FKA IONIAN TECHNOLOGIES, INC.); QUALITY ASSURED SERVICES INC. (FKA ZYCARE INC.); STANDING STONE, LLC; ESCREEN, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 036994/0192 →
NOTICE OF RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 030462 FRAME 0395 Recorded Jun 23, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
To: IONIAN TECHNOLOGIES, INC.
Reel/Frame 036009/0369 →
SUPPLEMENTAL INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded May 21, 2013
From: IONIAN TECHNOLOGIES, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 030462/0395 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2008
From: MAPLES, BRIAN K.; HOLMBERG, REBECCA C.; MILLER, ANDREW P.; PROVINS, JARROD; ROTH, RICHARD; MANDELL, JEFFREY
To: IONIAN TECHNOLOGIES, INC.
Reel/Frame 021171/0398 →